987Tip First-in-human Dose Escalation Trial of Fourth Generation Chimeric Antigen Receptor (CAR) T Cell Therapy (EU307) in Patients with Glypican-3 (GPC3) Positive Hepatocellular Carcinoma (HCC)
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined